Intensive chemotherapy in children with acute lymphoblastic leukemia (L‐2 protocol)

Seventy‐five consecutive children with acute lymphoblastic leukemia (ALL) were treated with a combination drug protocol (L‐2) consisting of three phases: remission induction, consolidation, and maintenance. Induction was achieved with prednisone, vincristine (VCR), and Daunorubicin (DNR). For consolidation, arabinosylcytosine (Ara‐C), and 6‐thioguanine (TG) followed by L‐asparaginase and 1,3‐bis (2‐chloroethyl)‐I‐nitrosourea (BCNU) were used. Maintenance consisted of administration of TG, cyclophosphamide, hydroxyurea, DNR, methotrexate (MTX), BCNU, Ara‐C, and VCR, given as 5‐day courses. Patients received periodic injections of intrathecal MTX for “prophylaxis” of the central nervous system (CNS) leukemia throughout the treatment course which was 3 years. Seventy‐four children achieved remission. Two died early in remission with serum hepatitis and I was lost to followup. Twelve patients have relapsed; in 2, the relapse was confined to CNS; in l, bone marrow and CNS relapse were concurrent. The remaining 59 have continued in complete remission from 1–42 months. Ten of the 12 children (excluding the hepatitis cases) who were registered on the L‐2 protocol for periods of 36 months or more remain free of disease. The height of the initial white blood cell count was found to be strongly related to the duration of complete remission. Tolerance to this regimen was generally good, the main side effect being hematologic depression. The results represent a 43‐month trial of L‐2 protocol. Conclusion as to the eventual duration of remissions awaits longer followup. Cancer 33:1490–1490, 1974.

[1]  Thomas L. Lincoln,et al.  Predicting progress, recognizing breakthroughs, and evaluating performance in the treatment of leukemia , 1973 .

[2]  H. Abu-Zahra,et al.  Treatment of acute myeloblastic leukemia in adults: remission induction with a combination of cyclophosphamide, cytarabine and vincristine. , 1972, Canadian Medical Association journal.

[3]  R. Aur,et al.  “Total therapy” studies of acute lymphocytic leukemia in children. Current results and prospects for cure , 1972, Cancer.

[4]  J. Holland,et al.  Chemotherapy of acute lymphocytic leukemia of childhood , 1972, Cancer.

[5]  E. Frei Combination cancer therapy: Presidential address. , 1972, Cancer research.

[6]  R. Aur,et al.  Nine years' experience with "total therapy" of childhood acute lymphocytic leukemia. , 1972, Pediatrics.

[7]  J. Fried,et al.  Changing concepts of treatment in acute leukemia. , 1971, The Medical clinics of North America.

[8]  R. Aur,et al.  Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia. , 1971, Blood.

[9]  R. Aur,et al.  Drug dosage and remission duration in childhood lymphocytic leukemia , 1971, Cancer.

[10]  D. Karnofsky,et al.  E. coli L‐asparaginase in the treatment of leukemia and solid tumors in 131 children , 1970, Cancer.

[11]  R. Heyn,et al.  Epidemiological factors and survival experience in 1770 children with acute leukemia treated by members of children's study group a between 1957 and 1964 , 1969, Cancer.

[12]  J. Wolff,et al.  Varying prednisone dosage in remission induction of previously untreated childhood leukemia , 1968, Cancer.

[13]  J. Bernard Acute leukemia treatment. , 1967, Cancer research.

[14]  C. Jasmin,et al.  Acute lymphoblastic leukaemia treated with a combination of prednisone, vincristine, and rubidomycin. Value of pathogen-free rooms. , 1967, Lancet.

[15]  E. Gehan A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. , 1965, Biometrika.

[16]  W. Zuelzer,et al.  IMPLICATIONS OF LONG-TERM SURVIVAL IN ACUTE STEM CELL LEUKEMIA OF CHILDHOOD TREATED WITH COMPOSITE CYCLIC THERAPY. , 1964, Blood.

[17]  M. Karoń Problems in the evaluation of long-term results. , 1973, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[18]  W. Krivit,et al.  The need for chemotherapy after prolonged complete remission in acute leukemia of childhood. , 1970, The Journal of pediatrics.